Reports

1. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors (2011)
Pollini, R. A., Banta-Green, C. J., Cuevas-Mota, J., Metzner, M., Teshale, E., & Garfein, R. S. (2011). Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Substance abuse and rehabilitation, 2, 173.

2. Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004 (2008) 
Amon, J. J., Garfein, R. S., Ahdieh-Grant, L., Armstrong, G. L., Ouellet, L. J., Latka, M. H., ... & Jarlais, D. D. (2008). Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994–2004. Clinical Infectious Diseases, 46(12), 1852-1858.

3. Self-Reported Hepatitis C Virus Antibody Status and Risk Behavior in Young Injectors (2006)
Hagan, H., Campbell, J., Thiede, H., Strathdee, S., Ouellet, L., Kapadia, F., ... & Garfein, R. S. (2006). Self-reported hepatitis C virus antibody status and risk behavior in young injectors. Public health reports, 121(6), 710-719.

4. Variability in the Incidence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection among Young Injecting Drug Users in New York City (2003)
Des Jarlais, D. C., Diaz, T., Perlis, T., Vlahov, D., Maslow, C., Latka, M., ... & Williams, I. (2003). Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. American Journal of Epidemiology, 157(5), 467-471.